Danaher Co. (NYSE:DHR) Shares Acquired by Ironvine Capital Partners LLC

Ironvine Capital Partners LLC boosted its position in Danaher Co. (NYSE:DHR - Free Report) by 23.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,225 shares of the conglomerate's stock after purchasing an additional 23,906 shares during the period. Danaher comprises approximately 3.1% of Ironvine Capital Partners LLC's holdings, making the stock its 16th largest position. Ironvine Capital Partners LLC's holdings in Danaher were worth $29,204,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the 4th quarter worth $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC lifted its stake in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research analyst reports. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. UBS Group decreased their target price on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday. Guggenheim restated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday. Finally, The Goldman Sachs Group decreased their price objective on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $264.40.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company's stock.

Danaher Trading Up 0.4 %

Shares of DHR stock traded up $0.87 on Friday, reaching $197.37. 2,608,666 shares of the stock were exchanged, compared to its average volume of 3,352,398. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market cap of $141.06 billion, a P/E ratio of 37.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The firm has a 50 day moving average of $200.87 and a two-hundred day moving average of $224.58. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, research analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Friday, March 28th. Danaher's payout ratio is currently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.